Berlin
Germany
94
2023-11-09
The entities that hold a legal rights for patent applications filed by inventor Struck Joachim:
Joachim Struck from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
Anti-ADM-antibodies binding to the free N-terminus for accelerated transition of ADM-Gly to bio-ADM in patients with ADM-Gly/ bio-ADM ratio above a threshold and combination with vitamin C
#2 | 2022-08-25THERAPY MONITORING UNDER TREATMENT WITH AN ANTI-ADRENOMEDULLIN (ADM) BINDER
#3 | 2019-07-25Procalcitonin for the prognosis of adverse events
#4 | 2019-07-25Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
#5 | 2019-02-07IMMUNOASSAY FOR THE DETECTION OF PROCALCITONIN
#6 | 2018-09-06Method of obtaining a binder to prepro-vasopressin or fragments thereof
#7 | 2018-05-24DETERMINATION OF A MIDREGIONAL PROADRENOMEDULLIN PARTIAL PEPTIDE IN BIOLOGICAL FLUIDS FOR DIAGNOSTIC PURPOSES, AND IMMUNOASSAYS FOR CARRYING OUT SUCH A DETERMINATION
#8 | 2018-02-22RISK ASSESSMENT FOR ANTIBIOTICS TREATMENT IN PATIENTS SUFFERING FROM PRIMARY NON-INFECTIOUS DISEASE BY DETERMINING THE LEVEL OF PROCALCITONIN
#9 | 2017-12-28Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
#10 | 2017-12-28PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE
#11 | 2017-08-24DIAGNOSTIC METHOD FOR DISORDERS USING COPEPTIN
#12 | 2017-05-11Immunoassay for the detection of procalcitonin
#13 | 2017-03-02Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
#14 | 2016-11-03Prognosis of adverse events in patients with suspected chronic heart failure
#15 | 2016-06-16Diagnosis and Risk Assessment of Pancreatic Diabetes Using MR-proADM
#16 | 2016-06-09DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1
#17 | 2016-05-26Augurin immunoassay
#18 | 2016-05-12Method for risk stratification in stable coronary artery disease
#19 | 2016-05-12In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient
#20 | 2015-10-15Arginine vasopressin pro-hormone as predictive biomarker for diabetes
#21 | 2015-09-03Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
#22 | 2015-07-09METHODS OF DIAGNOSIS AND RISK STRATIFICATION OF ADVERSE EVENTS IN POST MYOCARDIAL INFARCTION PATIENTS USING PRO-ADRENOMEDULLIN
#23 | 2015-04-30BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS, ASSESSMENT AND THERAPY STRATIFICATION OF SYNCOPE
#24 | 2015-03-26Method for risk stratification in stable coronary artery disease
#25 | 2015-03-19Prognosis of adverse events in patients with suspected chronic heart failure
#26 | 2015-01-08Diagnosis and risk stratification by determining the marker CT-proADM
#27 | 2014-11-13METHOD OF OBTAINING A BINDER TO PREPRO-VASOPRESSIN OR FRAGMENTS THEREOF
#28 | 2014-10-30Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination
#29 | 2014-08-14DIAGNOSTIC USE OF PROSOMATOSTATIN
#30 | 2014-02-20BIOMARKERS FOR THE PREDICTION OF INCIDENT CANCER
#31 | 2013-12-26Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II
#32 | 2013-11-14PROGNOSIS AND RISK ASSESSMENT OF PATIENTS WITH NON-SPECIFIC COMPLAINTS
#33 | 2013-10-10Diagnosis and risk stratification by determining the marker CT-proADM
#34 | 2013-05-16Method for the selective detection and measurement of procalcitonin 1-116 and amino-terminal peptides of procalcitonin comprising amino acids 1 and 2 of procalcitonin 1-116
#35 | 2013-04-18PROCALCITONIN FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS AND GUIDANCE OF ANTIBIOTIC TREATMENT IN PATIENTS WITH NON-SPECIFIC COMPLAINTS
#36 | 2012-10-25DIAGNOSIS AND RISK STRATIFICATION OF INFECTIONS AND CHRONIC DISEASES OF THE RESPIRATORY TRACT AND LUNGS BY MEANS OF PROVASOPRESSIN, PARTICULARLY COPEPTIN OR NEUROPHYSIN II
#37 | 2012-10-18Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
#38 | 2012-06-14PROCALCITONIN FOR THE PROGNOSIS OF ADVERSE EVENTS
#39 | 2012-06-07Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction
#40 | 2012-05-24DIAGNOSTICAL USE OF PEROXIREDOXIN 4
#41 | 2012-05-17Method for risk stratification in stable coronary artery disease
#42 | 2012-05-17IMMUNOASSAY FOR THE DETECTION OF PROCALCITONIN
#43 | 2012-04-26Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
#44 | 2012-03-29Use of carbamoyl phosphate synthetase 1 (CPS) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases
#45 | 2012-01-05Prognostic biomarkers for the progression of primary chronic kidney disease
#46 | 2012-01-05BIOMARKER FOR THE PREDICTION OF FIRST ADVERSE EVENTS
#47 | 2011-12-29Arginine vasopressin pro-hormone as predictive biomarker for diabetes
#48 | 2011-09-22AZUROPHILIC GRANULE PROTEASES AS MARKERS IN CARDIOLOGICAL DISEASES
#49 | 2011-07-14Marker for graft failure and mortality
#50 | 2011-07-07Use of Carbamoyl Phosphate Synthetase 1 (Cps) as a Humoral Biomarker For the Diagnosis of Tumour Diseases and Chronic Inflammatory Intestinal Diseases
#51 | 2011-06-23Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
#52 | 2011-06-09USE OF PROCALCITONIN (PCT) IN RISK STRATIFICATION AND PROGNOSIS OF PATIENTS WITH A PRIMARY, NON-INFECTIOUS DISEASE
#53 | 2011-05-19USE OF PROCALCITONIN (PCT) IN PROGNOSIS FOLLOWING ACUTE CORONARY SYNDROMES
#54 | 2011-05-12PRO-ENDOTHELIN-1 FOR THE PREDICTION OF IMPAIRED PEAK OXYGEN CONSUMPTION
#55 | 2011-05-12PRO-ENDOTHELIN-1 LEVELS FOR THE PREDICTION OF RISK OF TACHYARRHYTMIC EVENTS
#56 | 2011-02-17Diagnosis and risk stratification using NT-proET-1
#57 | 2011-01-27Method for detecting analytes
#58 | 2011-01-13DIAGNOSTIC METHOD FOR DISORDERS USING COPEPTIN
#59 | 2011-01-13Method for the detection of sepsis by determining peptide prohormone levels
#60 | 2010-11-11Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease
#61 | 2010-08-19Methods of treatment using ADM antibodies
#62 | 2010-06-17Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP
#63 | 2010-06-10Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients
#64 | 2010-05-25Use of blocking anti-TSH-receptor-antibodies in the therapy of hyperthyreoses and monoclonal antibodies for a use of this type
#65 | 2010-04-15DIAGNOSIS AND RISK STRATIFICATION OF CARDIAC INSUFFICIENCY USING NEUROPHYSIN
#66 | 2010-03-04Antibodies for the selective determination of procalcitonin 1-116
#67 | 2010-02-25Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failure
#68 | 2010-02-18Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
#69 | 2010-02-11Diagnosis and risk stratification by determining the marker CT-proADM
#70 | 2010-02-11DIAGNOSIS AND RISK ASSESSMENT OF PANCREATIC DIABETES USING MR-PROADM
#71 | 2010-02-04Risk stratification for acute coronary syndrome by determining copeptin
#72 | 2009-12-17IN VITRO METHOD FOR DIAGNOSING NEURODEGENERATIVE DISEASES
#73 | 2009-09-17Method for the detection of sepsis using procalcitonin-3-116
#74 | 2009-09-03Diagnostic method for disorders using copeptin
#75 | 2009-08-27Method for determining sepsis using pro-ADM
#76 | 2009-07-30Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
#77 | 2009-07-09In vitro method for the detection of early-stage liver damage
#78 | 2009-05-28Determination of short-chain SRL alcohol dehydrogenase (DHRS4) as a biomarker for inflammations and infections
#79 | 2009-04-16Method for determining sepsis using pro-BNP
#80 | 2009-03-03Method for determining sepsis using pro-ANF
#81 | 2009-01-08Diagnosis of Sepsis by the Selective Determination of the Concentration of Cu/Zn Superoxide Dismutase (Cu/Zn Sod) in Patient Samples
#82 | 2008-10-09Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity
#83 | 2008-09-04Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
#84 | 2008-07-24USES OF CARBAMOYL PHOSPHATE SYNTHETASE 1 (CPS 1) AND IT'S FRAGMENTS FOR THE DIAGNOSIS OF LIVER DISEASES
#85 | 2008-01-31Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
#86 | 2007-09-13Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination
#87 | 2006-12-26Inflammation-specific peptides and the uses thereof
#88 | 2006-10-19Sandwich immunoassay for identifying partial proANP peptides
#89 | 2006-06-01Uses of carbamoyl phosphate synthetase for the diagnois of inflammatory diseases and sepsis
#90 | 2006-03-21Receptor binding assays and reagent kit for detecting TSH receptor autoantibodies
#91 | 2006-02-16Use of the glycine n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis
#92 | 2006-02-09Method for diagnosing inflammatory diseases and infections by the determination of LASP-1 immunoreactivity
#93 | 2005-06-16Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
#94 | 2005-03-24CHP for use as marker for sepsis-type inflammatory diseases
198696 ⎘